In Vitro Susceptibility of Clinical and Carrier Strains of Staphylococcus aureus to STAFAL® Phage Preparation DOI Open Access
Marek Straka,

Zuzana Hubenáková,

Lucia Janošíková

и другие.

International Journal of Molecular Sciences, Год журнала: 2024, Номер 25(23), С. 12885 - 12885

Опубликована: Ноя. 29, 2024

The treatment of infections caused by

Язык: Английский

Bacteriophage therapy for multidrug-resistant infections: current technologies and therapeutic approaches DOI Creative Commons
Minyoung Kevin Kim, Gina A. Suh, Grace Cullen

и другие.

Journal of Clinical Investigation, Год журнала: 2025, Номер 135(5)

Опубликована: Март 2, 2025

Bacteriophage (phage) therapy has emerged as a promising solution to combat the growing crisis of multidrug-resistant (MDR) infections. There are several international centers actively engaged in implementation phage therapy, and recent case series have reported encouraging success rates patients receiving personalized, compassionate for difficult-to-treat Nonetheless, substantial hurdles remain way more widespread adoption consistent success. This Review offers comprehensive overview current technologies therapeutic approaches. We first delineate common steps development, from bank establishment clinical administration, examine spectrum approaches, personalized fixed cocktails. Using framework conventional drug development pipeline, we then identify critical knowledge gaps areas such cocktail design, formulation, pharmacology, trial design. conclude that, while holds promise, structured pipeline sustained government support crucial MDR

Язык: Английский

Процитировано

3

Phage therapy: an alternative treatment modality for MDR bacterial infections DOI

Namrata Pal,

Poonam Sharma, Manoj Kumawat

и другие.

Infectious Diseases, Год журнала: 2024, Номер 56(10), С. 785 - 817

Опубликована: Июль 17, 2024

The increasing global incidence of multidrug-resistant (MDR) bacterial infections threatens public health and compromises various aspects modern medicine. Recognising the urgency this issue, World Health Organisation has prioritised development novel antimicrobials to combat ESKAPEE pathogens. Comprising

Язык: Английский

Процитировано

12

Non-antibiotic therapies for multidrug-resistant gastrointestinal infections: an overview of the use of probiotics, natural compounds, and bacteriophages DOI Creative Commons
Manuela Oliveira, Áurea Madureira-Carvalho,

Ricardo Jorge Dinis-Oliveira

и другие.

Frontiers in Antibiotics, Год журнала: 2025, Номер 4

Опубликована: Май 6, 2025

The worldwide increasing frequency and severity of multidrug-resistant gastrointestinal (MDR-GI) infections not only raises awareness the debilities conventional antibiotic treatments but also highlights demand for alternative interventions. One these alternatives is probiotics, harmless bacteria that compete with pathogenic species, which have been considered beneficial due to their therapeutic potential since they strengthen mucosal barrier modulate host immune response. Other natural compounds (e.g., polyphenols, flavonoids, essential oils) present diverse antimicrobial mechanisms, are promising mitigate resistant pathogens. Finally, bacteriophages, viruses target specific bacteria, constitute a precise approach in MDR lysed or disrupted by biofilms formed during colonization without compromising normal gut microbiome. Therefore, manuscript provides an integrated perspective on non-antibiotic therapies manage MDR-GI infections; this purpose, it covers aspects such as action current clinical applications, challenges limit broader application practice. combining approaches personalizing infection adjusted patients' microbiome profiles discussed, aiming enhance efficacy reduce resistance risks. importance continued research development optimize debated, addressing need surpass regulatory barriers conducting large-scale trials establish safety alternatives. This overview knowledge contributes ongoing efforts develop sustainable strategies combat global burden resistance.

Язык: Английский

Процитировано

0

Characterization and Genomic Analysis of a New Bacteriophage Klebsiella pneumoniae CTF-1 from Turkey DOI
Kübra Can, Edip Tokuç, Halil Kurt

и другие.

Опубликована: Май 14, 2025

Abstract Background Klebsiella pneumoniae is a clinically important pathogen causing respiratory tract infections, pneumonia, wound urinary infections and sepsis. It on the priority list of World Health Organization (WHO) due to resistant it causes. The K. CTF1 phage novel lytic with highest overall similarity 82.19% against isolated from clinical infections. In this study, whole genome analysis was conducted. Results has linear double-stranded DNA 40,841 bp long 53.1% GC content. Totally 44 protein coding genes were identified in genome. 31 which assigned functions as replication, packaging, structural proteins or lysis. CTF-1 member Przondovirus genus within Caudovirales order. objective research explore effectiveness CTF-I bacteriophage isolate panresistant K. pneumoniae isolates. effective 22 (88%) 25 strains. optimum efficacy 37–45°C, optimal pH between 4–9. latent time cycle around 40 min burst size 92 PFU/mL. Conclusions an excellent candidate for therapy its high activity Klebsiella lack antibiotic resistance genes, toxins, virulence factors integrase genes.

Язык: Английский

Процитировано

0

Lytic Spectra of Tailed Bacteriophages: A Systematic Review and Meta-Analysis DOI Creative Commons
Ivan M. Pchelin,

Andrei V. Smolensky,

Daniil V. Azarov

и другие.

Viruses, Год журнала: 2024, Номер 16(12), С. 1879 - 1879

Опубликована: Дек. 4, 2024

As natural predators of bacteria, tailed bacteriophages can be used in biocontrol applications, including antimicrobial therapy. Also, phage lysis is a detrimental factor technological processes based on bacterial growth and metabolism. The spectrum bacteria interact with known as the host range. Phage science produced vast amount range data. However, there has been no attempt to analyse these data from viewpoint modern taxonomy. Here, we performed meta-analysis spotting plaquing obtained strains production species. main metric our study was value calculated ratio lysed number tested strains. We found boundary between narrow broad ranges phages taken whole. Family-level groups strictly lytic had significantly different median values 0.18 (Drexlerviridae) 0.70 (Herelleviridae). In Escherichia coli phages, were associated decreased efficiency plating. Bacteriophage morphology, genome size, tRNA-coding genes genomes did not correlate values. From perspective species, varied 0.04 infecting Acinetobacter baumannii 0.73 Staphylococcus aureus phages. Taken together, results imply that taxonomy their hosts predictive intraspecies ranges.

Язык: Английский

Процитировано

1

Evaluating the effectiveness and safety of a novel phage cocktail as a biocontrol of Salmonella in biofilm, food products, and broiler chicken DOI Creative Commons
Narges Torkashvand, Haniyeh Kamyab,

Parisa Aarabi

и другие.

Frontiers in Microbiology, Год журнала: 2024, Номер 15

Опубликована: Ноя. 28, 2024

is a foodborne pathogen of animal and public health significance. Considering the disadvantages antibiotics or chemical preservatives traditionally used to eliminate this pathogen, attention has shifted, in recent years, toward biocontrol agents such as bacteriophages, either separately combination prevent food contamination. However, extensive use phage-based industry requires further studies ensure their safety efficacy. In present study, we investigated effectiveness phage cocktail, cocktail comprising three pre-characterized

Язык: Английский

Процитировано

0

In Vitro Susceptibility of Clinical and Carrier Strains of Staphylococcus aureus to STAFAL® Phage Preparation DOI Open Access
Marek Straka,

Zuzana Hubenáková,

Lucia Janošíková

и другие.

International Journal of Molecular Sciences, Год журнала: 2024, Номер 25(23), С. 12885 - 12885

Опубликована: Ноя. 29, 2024

The treatment of infections caused by

Язык: Английский

Процитировано

0